Výsledky vyhledávání

Akademický článek

Safety, tolerability and efficacy of a novel self‐use biodegradable device for management of obesity

Autor: H. Shirin, V. Richter, S. Matalon, D. Abramowich, A. Maliar, E. Shachar, S. F. Moss, E. Broide

Publikováno v: Obesity Science & Practice, Vol 5, Iss 4, Pp 376-382 (2019)

Summary Objective Obesity is a major public health issue with significant impact on quality of life, morbidity and mortality rates. It is estimated that if the current trends continue, 18% of men and 21% of women worldwide will be obese by 2025. All

Externí odkaz: https://doaj.org/article/8e84bfa487704acd9645be0545e8e9b4

Zobrazit plný text záznamu

OP16 Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn’s disease by number and type of prior biologics

Autor: L Peyrin-Biroulet, G Parkes, C Rodríguez, J Siffledeen, J Wright, E Broide, S Ford, A P Lacerda, J Oomen, A Garrison, S Berg, D T Rubin

Publikováno v: Journal of Crohn's and Colitis. 17:i20-i22

Background Biologic therapies are used to treat moderate-to-severe Crohn’s Disease (CD), but many patients eventually lose response to them. With new potential therapies for CD, understanding their efficacy after patients undergo biologic treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1528d1677ee5a570a82a82b109e8d14
https://doi.org/10.1093/ecco-jcc/jjac190.0016

Zobrazit plný text záznamu

P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study

Autor: O Atia, Z Shavit-Brunschwig, A Quteineh, R Lev-Tzion, R Stein, E Broide, D Urlep, J Hyams, M Aloi, D S Shouval, A Assa, S Hussey, J Markowitz, A Yerushalmy, E Miele, R K Russell, D Turner

Publikováno v: Journal of Crohn's and Colitis. 17:i904-i905

Background We previously reported the effectiveness of vedolizumab (VDZ) to induce remission in children with CD and UC enrolled in the prospective,multicenter VEDOKIDS study.In this extended analysis,we aimed to explore the effectiveness and safety

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c018d8b90dd0745f42a43e90943302d0
https://doi.org/10.1093/ecco-jcc/jjac190.0904

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P480 Comparison of executive functioning profiles among adults with Crohn’s disease and Ulcerative colitis

Autor: D Zelnik Yovel, S Meyer, V Richter, H Shirin, E Broide

Publikováno v: Journal of Crohn's and Colitis. 16:i448-i449

Background Psychological factors that influence inflammatory bowel disease (IBD) outcome can impact patients’ ability to cope and aid the management of the disease. Executive functions (EFs) are cognitive processes, which enable the achievement of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9482656375832912bb1fa6aa14aa09b3
https://doi.org/10.1093/ecco-jcc/jjab232.607

Zobrazit plný text záznamu

OP05 Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study

Autor: Z Shavit, R Stein, M Aloi, O Ledder, G Focht, D Urlep, J Hyams, E Broide, B Vais, J Levine, D Shouval, M Matar, A Assa, J Rosh, S Hussey, J Markowitz, A Yerushalmy-Feler, E Miele, R Shaoul, R K Russell, D Turner

Publikováno v: Journal of Crohn's and Colitis. 16:i005-i006

Background Limited data are available on the use of Vedolizumab (VDZ) in paediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC). We evaluated the effectiveness and safety of VDZ to induce remission at week 14 in the prospective, multicenter VE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5cafb6fe58567d416fb0f1db81195fe5
https://doi.org/10.1093/ecco-jcc/jjab232.004

Zobrazit plný text záznamu

P147 Do IBD Patient Treatment Outcomes Expectations Differ by Ethnicity and Gender?

Autor: E Broide, V Richter, A Mari, T Khoury, H Shirin, T Naftali

Publikováno v: Journal of Crohn's and Colitis. 16:i226-i226

Background Understanding IBD Patient’s expectations of treatments outcomes may improve understanding of patient’s needs. These expectations may differ in different ethnic groups. Awareness of the patient’s expectations and preferences will decr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ddf2eaa6ad05653cbab829e060a2c49a
https://doi.org/10.1093/ecco-jcc/jjab232.275

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání